U.S. Markets open in 6 hrs 28 mins
  • S&P Futures

    3,786.50
    -16.75 (-0.44%)
     
  • Dow Futures

    30,248.00
    -117.00 (-0.39%)
     
  • Nasdaq Futures

    11,586.50
    -54.25 (-0.47%)
     
  • Russell 2000 Futures

    1,770.50
    -11.00 (-0.62%)
     
  • Crude Oil

    86.55
    +0.03 (+0.03%)
     
  • Gold

    1,736.40
    +5.90 (+0.34%)
     
  • Silver

    21.05
    -0.05 (-0.23%)
     
  • EUR/USD

    0.9981
    -0.0005 (-0.0499%)
     
  • 10-Yr Bond

    3.6170
    0.0000 (0.00%)
     
  • Vix

    29.07
    -1.03 (-3.42%)
     
  • GBP/USD

    1.1468
    -0.0007 (-0.0608%)
     
  • USD/JPY

    144.2620
    +0.0630 (+0.0437%)
     
  • BTC-USD

    20,257.53
    +431.40 (+2.18%)
     
  • CMC Crypto 200

    459.34
    +13.91 (+3.12%)
     
  • FTSE 100

    7,086.46
    0.00 (0.00%)
     
  • Nikkei 225

    27,120.53
    +128.32 (+0.48%)
     

USD 7.22 Bn growth expected in Myopia and Presbyopia Treatment Market -- Evolving Opportunities with AbbVie Inc. and Alcon Inc.

·12 min read

NEW YORK, Sept. 14, 2022 /PRNewswire/ -- The myopia and presbyopia treatment market size is expected to grow by USD 7.22 billion between 2021 and 2026, accelerating at a CAGR of 7.94% during the forecast period. The report identifies AbbVie Inc., Alcon Inc., Bausch Health Co. Inc., BVI Medical Inc., and Carl Zeiss AG as some of the key vendors. With the presence of several global and regional vendors, global myopia and presbyopia market is fragmented. The competition in the market is expected to intensify over the forecast period with the launch of new products by vendors.

Technavio has announced its latest market research report titled Myopia and Presbyopia Treatment Market by Type and Geography - Forecast and Analysis 2022-2026
Technavio has announced its latest market research report titled Myopia and Presbyopia Treatment Market by Type and Geography - Forecast and Analysis 2022-2026

Understand the scope of the full report. Download PDF Report Sample

The report segments the market by type (myopia treatment and presbyopia treatment) and geography (Asia, North America, Europe, and the Rest of the World (ROW)).

By type, the market will observe significant growth in the myopia treatment segment over the forecast period. The segment is mainly driven by the rising prevalence of myopia and the availability of advanced products to treat the condition.

By region, Asia will emerge as the major market, occupying 38% of the global market share. The increasing incidence of myopia in countries such as Japan, Singapore, China, and South Korea is driving the growth of the regional market.

The market is driven by the increasing prevalence of myopia and presbyopia. In 2020, 1.1 billion people across the world had distance vision impairment or uncorrected presbyopia. The prevalence of this condition is high in regions such as East Asia, South Asia, and Southeast Asia. In addition, according to the WHO, half of the world population may be myopic by 2050. Thus, with the growing prevalence of myopia and presbyopia, the demand for treatment options such as contact lenses, concave lenses, and corrective lenses is set to increase over the forecast period. This, in turn, will drive the growth of the market in focus.

Vendor Landscape:

Global myopia and presbyopia treatment market is fragmented. The vendors in the market compete in terms of pricing, R&D, quality, geographical coverage, product offerings, and the development of technologically advanced products. The competition in the market will become more intense with the increase in the number of myopia and presbyopia incidences requiring surgical treatments. Besides, key vendors in the market are continuously launching new products to increase their market share in global myopia and presbyopia treatment market. All these factors are expected to intensify the competition in the market during the forecast period.

Technavio considers the following as the dominant players in the market.

  • AbbVie Inc.

  • Alcon Inc.

  • Bausch Health Co. Inc.

  • BVI Medical Inc.

  • Carl Zeiss AG

  • Essilor International SAS

  • Haag Streit Group

  • Johnson and Johnson

  • NIDEK Co. Ltd

  • Ophtec BV

  • Orasis Pharmaceuticals Inc.

  • Regeneron Pharmaceuticals Inc.

  • Sanjeevan School For Perfect Eyesight

  • Sydnexis Inc.

  • The Cooper Companies Inc.

  • Topcon Corp.

  • Ziemer Ophthalmic Systems AG

Technavio's sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request Sample Report Here

Related Reports:

Myopia and Presbyopia Treatment Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 7.94%

Market growth 2022-2026

USD 7.22 billion

Market structure

Fragmented

YoY growth (%)

7.43

Regional analysis

Asia, North America, Europe, and Rest of World (ROW)

Performing market contribution

Asia at 38%

Key consumer countries

US, UK, China, Japan, and the Republic of Korea

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

AbbVie Inc., Alcon Inc., Bausch Health Co. Inc., BVI Medical Inc., Carl Zeiss AG, Essilor International SAS, Haag Streit Group, Johnson and Johnson, NIDEK Co. Ltd, Ophtec BV, Orasis Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Sanjeevan School For Perfect Eyesight, Sydnexis Inc., The Cooper Companies Inc., Topcon Corp., and Ziemer Ophthalmic Systems AG

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of Contents:

1 Executive Summary

  • 1.1 Market overview

2 Market Landscape

  • 2.1 Market ecosystem

3 Market Sizing

  • 3.1 Market definition

  • 3.2 Market segment analysis

  • 3.3 Market size 2021

  • 3.4 Market outlook: Forecast for 2021-2026

4 Five Forces Analysis

  • 4.1 Five forces summary

  • 4.2 Bargaining power of buyers

  • 4.3 Bargaining power of suppliers

  • 4.4 Threat of new entrants

  • 4.5 Threat of substitutes

  • 4.6 Threat of rivalry

  • 4.7 Market condition

5 Market Segmentation by Type

  • 5.1 Market segments

  • 5.2 Comparison by Type

  • 5.3 Myopia treatment - Market size and forecast 2021-2026

  • 5.4 Presbyopia treatment - Market size and forecast 2021-2026

  • 5.5 Market opportunity by Type

6 Customer Landscape

  • 6.1 Customer landscape overview

7 Geographic Landscape

  • 7.1 Geographic segmentation

  • 7.2 Geographic comparison

  • 7.3 Asia - Market size and forecast 2021-2026

  • 7.4 North America - Market size and forecast 2021-2026

  • 7.5 Europe - Market size and forecast 2021-2026

  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026

  • 7.7 China - Market size and forecast 2021-2026

  • 7.8 US - Market size and forecast 2021-2026

  • 7.9 Japan - Market size and forecast 2021-2026

  • 7.10 Republic of Korea - Market size and forecast 2021-2026

  • 7.11 UK - Market size and forecast 2021-2026

  • 7.12 Market opportunity by geography

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers

  • 8.2 Market challenges

  • 8.3 Impact of drivers and challenges

  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview

  • 9.2 Vendor landscape

  • 9.3 Landscape disruption

  • 9.4 Industry risks

10 Vendor Analysis

  • 10.1 Vendors covered

  • 10.2 Market positioning of vendors

  • 10.3 Alcon Inc.

  • 10.4 Bausch Health Co. Inc.

  • 10.5 Carl Zeiss AG

  • 10.6 Essilor International SAS

  • 10.7 Haag Streit Group

  • 10.8 Johnson and Johnson

  • 10.9 NIDEK Co. Ltd

  • 10.10 Ophtec BV

  • 10.11 Topcon Corp.

  • 10.12 Ziemer Ophthalmic Systems AG

11 Appendix

  • 11.1 Scope of the report

  • 11.2 Inclusions and exclusions checklist

  • 11.3 Currency conversion rates for US$

  • 11.4 Research methodology

  • 11.5 List of abbreviations

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Technavio (PRNewsfoto/Technavio)
Technavio (PRNewsfoto/Technavio)
Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/usd-7-22-bn-growth-expected-in-myopia-and-presbyopia-treatment-market--evolving-opportunities-with-abbvie-inc-and-alcon-inc-301623528.html

SOURCE Technavio